Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Antibody Library Technologies Market by Type (Phage Display, Ribosome Display, Yeast Display, Mammalian Cell Display), By Application (Biopharmaceutical Companies, Academic and Research Institutes, Others) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Antibody Library Technologies Market by Type (Phage Display, Ribosome Display, Yeast Display, Mammalian Cell Display), By Application (Biopharmaceutical Companies, Academic and Research Institutes, Others) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 300585 4200 Medical Care 377 246 Pages 4.9 (46)
                                          

Market Overview:


The global antibody library technologies market is expected to grow at a CAGR of 10.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for monoclonal antibodies (mAbs) and rising prevalence of chronic diseases. The global antibody library technologies market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into phage display, ribosome display, yeast display, and mammalian cell display. The phage display segment is expected to account for a major share of the global antibody library technologies market in 2018 owing to its advantages such as high specificity and affinity for antigen binding as well as easy scalability. By application, biopharmaceutical companies are expected to account for a major share of the global antibody library technologies market in 2018 owing to their growing demand for mAbs used in drug discovery and development processes.


Global Antibody Library Technologies Industry Outlook


Product Definition:


Antibody library technologies are used to generate libraries of antibodies from a variety of sources, including B cells, phage display, and yeast surface display. These libraries can be screened for the presence of specific antibodies that bind to a target molecule. The importance of antibody library technologies is that they allow researchers to identify antibodies that specifically bind to a target molecule. This can be useful for developing diagnostic tools or therapeutics.


Phage Display:


Phage display is a method of selecting and screening antibody binding proteins from large libraries for their ability to bind an antigen. It is based on the principle that antibodies can be displayed on the surface of phage particles, which are used as carriers for protein purification. The selection process involves affinity chromatography followed by panning using an appropriate resin.


Ribosome Display:


Ribosome Display is a new technology that allows the users to view and analyze the protein content of cells. It also helps in determining the function of proteins. This technology makes use of an artificial intelligence-based algorithm, which enables it to scan through vast amounts of data very quickly. The output from this scanning is then used by researchers for further analysis.


Application Insights:


The others segment held the largest share of the global market in 2017. This can be attributed to a rise in demand for polyclonal and monoclonal antibodies from various industries such as diagnostics, therapeutics, and food & beverages. In addition, factors such as an increase in research activities by biopharmaceutical companies are expected to drive growth during the forecast period.


Phage display is most commonly used method for generating polyclonal antibodies due to its ease of use and low cost compared to other methods. Phage displaying antibody libraries provide researchers with unique tools that enable rapid screening of large numbers of potential anti-targets without having them pass through mice or other animals; this reduces costs associated with animal testing while still enabling high throughput screening techniques (such as competitive assays). These advantages have led phage display antibody libraries to become one of the most popular ways for generating polyclonal antibodies across laboratories worldwide since their introduction over 20 years ago.


Regional Analysis:


North America dominated the global market in terms of revenue share in 2017. This can be attributed to the presence of a large number of biopharmaceutical companies, which are early adopters for advanced technologies and have established collaborative agreements with universities and research institutes for commercialization of their products. The U.S.-based company Thermo Fisher Scientific acquired Ribozyme engineering technology from CELGENE CORP., which is based on phage display principles, thereby strengthening its position in this region.


Asia Pacific is expected to grow at a lucrative rate over the forecast period owing to increasing R&D investments by pharmaceutical companies as well as government funding for life science-related projects across countries such as China, Japan, South Korea & India (ref.). These factors are anticipated to boost demand during the forecast period. Moreover, rising awareness about emerging technologies among people will further propel growth during the forecast period (ref.).


Growth Factors:


  • Increasing demand for monoclonal antibodies for drug discovery and development
  • Growing number of biotechnology and pharmaceutical companies
  • Rising prevalence of cancer and other diseases
  • Technological advancements in antibody library technologies
  • Growing investments in life sciences sector

Scope Of The Report

Report Attributes

Report Details

Report Title

Antibody Library Technologies Market Research Report

By Type

Phage Display, Ribosome Display, Yeast Display, Mammalian Cell Display

By Application

Biopharmaceutical Companies, Academic and Research Institutes, Others

By Companies

MorphoSys, Abzena, XOMA Corporation, AvantGen, Creative-Biolabs, AbCheck, Philogen, Adimab, Invenra, AnaptysBio, Abgent

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

246

Number of Tables & Figures

173

Customization Available

Yes, the report can be customized as per your need.


Global Antibody Library Technologies Market Report Segments:

The global Antibody Library Technologies market is segmented on the basis of:

Types

Phage Display, Ribosome Display, Yeast Display, Mammalian Cell Display

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Biopharmaceutical Companies, Academic and Research Institutes, Others

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. MorphoSys
  2. Abzena
  3. XOMA Corporation
  4. AvantGen
  5. Creative-Biolabs
  6. AbCheck
  7. Philogen
  8. Adimab
  9. Invenra
  10. AnaptysBio
  11. Abgent

Global Antibody Library Technologies Market Overview


Highlights of The Antibody Library Technologies Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Phage Display
    2. Ribosome Display
    3. Yeast Display
    4. Mammalian Cell Display
  1. By Application:

    1. Biopharmaceutical Companies
    2. Academic and Research Institutes
    3. Others
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Antibody Library Technologies Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Antibody Library Technologies Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Antibody Library Technologies (ALT) is a software company that provides innovative solutions for the management and analysis of antibody libraries. The company's products include the ALT Antibody Manager, which enables users to manage and analyze their antibody libraries in a centralized manner; the ALT Antibody Analyzer, which allows users to identify antibodies against specific targets; and the ALT Data Portal, which provides access to all of these tools from a single location.

Some of the major companies in the antibody library technologies market are MorphoSys, Abzena, XOMA Corporation, AvantGen, Creative-Biolabs, AbCheck, Philogen, Adimab, Invenra, AnaptysBio, Abgent.

The antibody library technologies market is expected to register a CAGR of 10.8%.

                                            
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Antibody Library Technologies Market Overview    4.1 Introduction       4.1.1 Market Taxonomy       4.1.2 Market Definition       4.1.3 Macro-Economic Factors Impacting the Market Growth    4.2 Antibody Library Technologies Market Dynamics       4.2.1 Market Drivers       4.2.2 Market Restraints       4.2.3 Market Opportunity    4.3 Antibody Library Technologies Market - Supply Chain Analysis       4.3.1 List of Key Suppliers       4.3.2 List of Key Distributors       4.3.3 List of Key Consumers    4.4 Key Forces Shaping the Antibody Library Technologies Market       4.4.1 Bargaining Power of Suppliers       4.4.2 Bargaining Power of Buyers       4.4.3 Threat of Substitution       4.4.4 Threat of New Entrants       4.4.5 Competitive Rivalry    4.5 Global Antibody Library Technologies Market Size & Forecast, 2018-2028       4.5.1 Antibody Library Technologies Market Size and Y-o-Y Growth       4.5.2 Antibody Library Technologies Market Absolute $ Opportunity

Chapter 5 Global Antibody Library Technologies Market Analysis and Forecast by Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities by Type
      5.1.2 Basis Point Share (BPS) Analysis by Type
      5.1.3 Absolute $ Opportunity Assessment by Type
   5.2 Antibody Library Technologies Market Size Forecast by Type
      5.2.1 Phage Display
      5.2.2 Ribosome Display
      5.2.3 Yeast Display
      5.2.4 Mammalian Cell Display
   5.3 Market Attractiveness Analysis by Type

Chapter 6 Global Antibody Library Technologies Market Analysis and Forecast by Applications
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Applications
      6.1.2 Basis Point Share (BPS) Analysis by Applications
      6.1.3 Absolute $ Opportunity Assessment by Applications
   6.2 Antibody Library Technologies Market Size Forecast by Applications
      6.2.1 Biopharmaceutical Companies
      6.2.2 Academic and Research Institutes
      6.2.3 Others
   6.3 Market Attractiveness Analysis by Applications

Chapter 7 Global Antibody Library Technologies Market Analysis and Forecast by Region
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities by Region
      7.1.2 Basis Point Share (BPS) Analysis by Region
      7.1.3 Absolute $ Opportunity Assessment by Region
   7.2 Antibody Library Technologies Market Size Forecast by Region
      7.2.1 North America
      7.2.2 Europe
      7.2.3 Asia Pacific
      7.2.4 Latin America
      7.2.5 Middle East & Africa (MEA)
   7.3 Market Attractiveness Analysis by Region

Chapter 8 Coronavirus Disease (COVID-19) Impact 
   8.1 Introduction 
   8.2 Current & Future Impact Analysis 
   8.3 Economic Impact Analysis 
   8.4 Government Policies 
   8.5 Investment Scenario

Chapter 9 North America Antibody Library Technologies Analysis and Forecast
   9.1 Introduction
   9.2 North America Antibody Library Technologies Market Size Forecast by Country
      9.2.1 U.S.
      9.2.2 Canada
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 North America Antibody Library Technologies Market Size Forecast by Type
      9.6.1 Phage Display
      9.6.2 Ribosome Display
      9.6.3 Yeast Display
      9.6.4 Mammalian Cell Display
   9.7 Basis Point Share (BPS) Analysis by Type 
   9.8 Absolute $ Opportunity Assessment by Type 
   9.9 Market Attractiveness Analysis by Type
   9.10 North America Antibody Library Technologies Market Size Forecast by Applications
      9.10.1 Biopharmaceutical Companies
      9.10.2 Academic and Research Institutes
      9.10.3 Others
   9.11 Basis Point Share (BPS) Analysis by Applications 
   9.12 Absolute $ Opportunity Assessment by Applications 
   9.13 Market Attractiveness Analysis by Applications

Chapter 10 Europe Antibody Library Technologies Analysis and Forecast
   10.1 Introduction
   10.2 Europe Antibody Library Technologies Market Size Forecast by Country
      10.2.1 Germany
      10.2.2 France
      10.2.3 Italy
      10.2.4 U.K.
      10.2.5 Spain
      10.2.6 Russia
      10.2.7 Rest of Europe
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Europe Antibody Library Technologies Market Size Forecast by Type
      10.6.1 Phage Display
      10.6.2 Ribosome Display
      10.6.3 Yeast Display
      10.6.4 Mammalian Cell Display
   10.7 Basis Point Share (BPS) Analysis by Type 
   10.8 Absolute $ Opportunity Assessment by Type 
   10.9 Market Attractiveness Analysis by Type
   10.10 Europe Antibody Library Technologies Market Size Forecast by Applications
      10.10.1 Biopharmaceutical Companies
      10.10.2 Academic and Research Institutes
      10.10.3 Others
   10.11 Basis Point Share (BPS) Analysis by Applications 
   10.12 Absolute $ Opportunity Assessment by Applications 
   10.13 Market Attractiveness Analysis by Applications

Chapter 11 Asia Pacific Antibody Library Technologies Analysis and Forecast
   11.1 Introduction
   11.2 Asia Pacific Antibody Library Technologies Market Size Forecast by Country
      11.2.1 China
      11.2.2 Japan
      11.2.3 South Korea
      11.2.4 India
      11.2.5 Australia
      11.2.6 South East Asia (SEA)
      11.2.7 Rest of Asia Pacific (APAC)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Asia Pacific Antibody Library Technologies Market Size Forecast by Type
      11.6.1 Phage Display
      11.6.2 Ribosome Display
      11.6.3 Yeast Display
      11.6.4 Mammalian Cell Display
   11.7 Basis Point Share (BPS) Analysis by Type 
   11.8 Absolute $ Opportunity Assessment by Type 
   11.9 Market Attractiveness Analysis by Type
   11.10 Asia Pacific Antibody Library Technologies Market Size Forecast by Applications
      11.10.1 Biopharmaceutical Companies
      11.10.2 Academic and Research Institutes
      11.10.3 Others
   11.11 Basis Point Share (BPS) Analysis by Applications 
   11.12 Absolute $ Opportunity Assessment by Applications 
   11.13 Market Attractiveness Analysis by Applications

Chapter 12 Latin America Antibody Library Technologies Analysis and Forecast
   12.1 Introduction
   12.2 Latin America Antibody Library Technologies Market Size Forecast by Country
      12.2.1 Brazil
      12.2.2 Mexico
      12.2.3 Rest of Latin America (LATAM)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Latin America Antibody Library Technologies Market Size Forecast by Type
      12.6.1 Phage Display
      12.6.2 Ribosome Display
      12.6.3 Yeast Display
      12.6.4 Mammalian Cell Display
   12.7 Basis Point Share (BPS) Analysis by Type 
   12.8 Absolute $ Opportunity Assessment by Type 
   12.9 Market Attractiveness Analysis by Type
   12.10 Latin America Antibody Library Technologies Market Size Forecast by Applications
      12.10.1 Biopharmaceutical Companies
      12.10.2 Academic and Research Institutes
      12.10.3 Others
   12.11 Basis Point Share (BPS) Analysis by Applications 
   12.12 Absolute $ Opportunity Assessment by Applications 
   12.13 Market Attractiveness Analysis by Applications

Chapter 13 Middle East & Africa (MEA) Antibody Library Technologies Analysis and Forecast
   13.1 Introduction
   13.2 Middle East & Africa (MEA) Antibody Library Technologies Market Size Forecast by Country
      13.2.1 Saudi Arabia
      13.2.2 South Africa
      13.2.3 UAE
      13.2.4 Rest of Middle East & Africa (MEA)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Middle East & Africa (MEA) Antibody Library Technologies Market Size Forecast by Type
      13.6.1 Phage Display
      13.6.2 Ribosome Display
      13.6.3 Yeast Display
      13.6.4 Mammalian Cell Display
   13.7 Basis Point Share (BPS) Analysis by Type 
   13.8 Absolute $ Opportunity Assessment by Type 
   13.9 Market Attractiveness Analysis by Type
   13.10 Middle East & Africa (MEA) Antibody Library Technologies Market Size Forecast by Applications
      13.10.1 Biopharmaceutical Companies
      13.10.2 Academic and Research Institutes
      13.10.3 Others
   13.11 Basis Point Share (BPS) Analysis by Applications 
   13.12 Absolute $ Opportunity Assessment by Applications 
   13.13 Market Attractiveness Analysis by Applications

Chapter 14 Competition Landscape 
   14.1 Antibody Library Technologies Market: Competitive Dashboard
   14.2 Global Antibody Library Technologies Market: Market Share Analysis, 2019
   14.3 Company Profiles (Details â€“ Overview, Financials, Developments, Strategy) 
      14.3.1 MorphoSys
      14.3.2 Abzena
      14.3.3 XOMA Corporation
      14.3.4 AvantGen
      14.3.5 Creative-Biolabs
      14.3.6 AbCheck
      14.3.7 Philogen
      14.3.8 Adimab
      14.3.9 Invenra
      14.3.10 AnaptysBio
      14.3.11 Abgent

Our Trusted Clients

Contact Us